April 15, 2024

Within3 in MeetingsNet

Our partnership extends engagement capabilities for pharma teams, supporting complex decision-making.
life science content engagement

In MeetingsNet, Within3 CEO Lance Hill discusses the company’s strategic partnership with Array Live, a life science event content engagement platform.

“We’ve observed the evolving market and realized our combined technologies fulfill a crucial need,” said Hill. “The partnership allows for clearer, more effective engagement strategies and data-driven support, which aids complex decision-making.”

From Array’s perspective, “the partnership extends the value of meetings beyond the ballroom,” said Cindy McVey, Array’s Director of Marketing. “Rather than seeing meetings as one-off events where information is shared with attendees and one data set is generated, stakeholders can now conduct meaningful work before, during, and after a meeting with a more robust data set that tells a holistic story about the understanding, opinions, and insights of meeting participants.”

“The key is the ability to develop a linear process where education, training, marketing, and generation of insights are integral before, during, and after meetings,” added McVey.

Read the full article in MeetingsNet to learn more about how Within3’s insights management platform and insights reporting work alongside the Array platform.

Related Posts:

AI in life science

Within3 in Pharmafield: understand the power of AI in life science

Within3 CTO, AI & Analytics Jason Smith talks to Pharmafield about AI technology in pharma, wearables, the impact of social media, and more.
medical affairs and digital influencers

Within3 in Journal of mHealth: Medical Affairs Should Work with Digital Influencers

Medical affairs teams can construct a more complete scientific narrative by branching out beyond traditional KOLs.
What is the insights gap?

Within3 on the MAPS Elevate Podcast

What is the insight gap, and why should you care? Within3’s Lance Hill and Mike Abbadessa discuss how life science companies could be missing out on important insight.